Cargando…

Metastatic Follicular Thyroid Carcinoma Secreting Thyroid Hormone and Radioiodine Avid without Stimulation: A Case Report and Literature Review

Introduction. This is an extremely rare case of a patient with metastatic follicular thyroid cancer who continued to produce thyroid hormone and was iodine scan positive without stimulation after thyroidectomy and radioiodine (I-131) therapy. Patient Findings. A 76-year-old Caucasian male was diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abid, Syed A., Stack, Brendan C., Bodenner, Donald L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220571/ https://www.ncbi.nlm.nih.gov/pubmed/25400957 http://dx.doi.org/10.1155/2014/584513

Ejemplares similares

Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
por: Ha, Le Ngoc, et al.
Publicado: (2021)

Correlation of thyroid hormone measurements with thyroid stimulating hormone stimulation test results in radioiodine‐treated cats
por: Wakeling, Jennifer, et al.
Publicado: (2020)

Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study
por: Lu, Yu-Ling, et al.
Publicado: (2021)

Myopathy following postoperative ablative radioiodine for follicular carcinoma of the thyroid
por: Price, Hermione C, et al.
Publicado: (2009)

Radioiodine Refractory Follicular Thyroid Cancer and Surgery for Cervical Relapse
por: Chiapponi, Costanza, et al.
Publicado: (2021)

Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
por: Sohn, Seo Young, et al.
Publicado: (2015)

Follicular thyroid cancer avid on C-11 Methionine PET/CT
por: Jochumsen, Mads Ryø, et al.
Publicado: (2018)

Metastatic Follicular Thyroid Carcinoma as a Cause of Low Serum Thyroxine with a Normal Thyroid Stimulating Hormone Level
por: Loh, Leh Teng, et al.
Publicado: (2017)

Weathering the Storm: Thyroid Storm Precipitated by Radioiodine Contrast in Metastatic Thyroid Carcinoma
por: Basida, Brinda, et al.
Publicado: (2021)

Effectiveness of Different Thyroid Stimulating Hormone Thresholds for Thyroid Hormone Withdrawal - Aided Radioiodine Ablation in Patients With Differentiated Thyroid Cancer: A Systematic Review and Meta - Analysis
por: Rojas, Tatiana, et al.
Publicado: (2021)

The Effectiveness of Recombinant Human Thyroid-Stimulating Hormone versus Thyroid Hormone Withdrawal Prior to Radioiodine Remnant Ablation in Thyroid Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Pak, Kyoungjune, et al.
Publicado: (2014)

THE ANATOMY OF SECRETION IN THE FOLLICULAR CELLS OF THE THYROID GLAND : II. The Effect of Acute Thyrotrophic Hormone Stimulation on the Secretory Apparatus
por: Wissig, Steven L.
Publicado: (1963)

Metastatic follicular carcinoma of thyroid in maxilla
por: Kumar, Caliaperoumal Santhosh, et al.
Publicado: (2013)

Positive BRAFV600E mutation of primary tumor influences radioiodine avidity but not prognosis of papillary thyroid cancer with lung metastases
por: Huang, Shuhui, et al.
Publicado: (2022)

Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
por: Tumino, Dario, et al.
Publicado: (2017)

Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.
por: Edmonds, C. J., et al.
Publicado: (1985)

Clear cell variant of follicular thyroid carcinoma with normal thyroid-stimulating hormone value: a case report
por: Sayar, Ilyas, et al.
Publicado: (2014)

Preparation with recombinant humanized thyroid-stimulating hormone before radioiodine ablation after thyroidectomy: a systematic review
por: Yoo, J., et al.
Publicado: (2009)

Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism
por: Jansen, S. W., et al.
Publicado: (2015)

Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
por: Jiang, Yongji, et al.
Publicado: (2023)

Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
por: Jafri, Sabih, et al.
Publicado: (2021)

A Follicular Stimulating Hormone Secreting Adenoma
por: De Croos, Mary, et al.
Publicado: (2021)

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
por: Pitoia, Fabián, et al.
Publicado: (2012)

Radioiodine therapy under rhTSH for follicular thyroid carcinoma with sellar metastasis and non-rising TSH
por: Taywade, Sameer Kamalakar, et al.
Publicado: (2016)

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
por: Minaldi, Elisa, et al.
Publicado: (2023)

Unusual Cutaneous Metastatic Follicular Thyroid Carcinoma
por: Rahman, G. A., et al.
Publicado: (2010)

An Update on the Pathophysiology and Diagnosis of Inappropriate Secretion of Thyroid-Stimulating Hormone
por: Ohba, Kenji
Publicado: (2021)

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer
por: Larson, Steven M., et al.
Publicado: (2017)

Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease
por: Ito, Mitsuru, et al.
Publicado: (2019)

False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
por: Barbaro, Daniele, et al.
Publicado: (2023)

Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy
por: Zhao, Teng, et al.
Publicado: (2017)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

Theophylline Increases the Uptake of Radioiodine by Mouse Thyroid
por: Lee, Jong Min, et al.
Publicado: (2004)

Radioiodine for thyroid cancer: sometimes, less is best
por: Padovani, Rosalia do Prado
Publicado: (2016)

Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
por: Wolfson, Robert M., et al.
Publicado: (2016)

Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
por: Zagar, Ivana, et al.
Publicado: (2012)

First Strike personalized predictive radioiodine prescription for inoperable metastatic differentiated thyroid cancer
por: Kao, Yung Hsiang
Publicado: (2023)

Oncocytic follicular nodules of the thyroid with or without chronic lymphocytic thyroiditis: An institutional experience
por: Canberk, Sule, et al.
Publicado: (2013)

Follicle-stimulating Hormone-secreting Pituitary Adenoma Accompanied by Painful Thyroiditis
por: Ichijo, Masashi, et al.
Publicado: (2019)

Thyroid follicular carcinoma presenting as metastatic skin nodules
por: Jehangir, Asad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m5i573e3dd8qli7hmc7t1uq4fg